Sai Life Sciences Ratios

Sai Life Sciences Ltd Ratios

The Sai Life Sciences Ltd Ratios page provides a complete fundamental analysis of Sai Life Sciences Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Sai Life Sciences Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Sai Life Sciences Ltd (NSE: SAILIFE, BSE: 544306) is currently trading at ₹972, with a market capitalization of ₹205.53B. As a major player in the Commercial services sector and Miscellaneous commercial services industry, Sai Life Sciences Ltd remains a key stock for fundamental analysis using Sai Life Sciences Ltd Ratios.

Sai Life Sciences Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Sai Life Sciences Ltd P/E ratio currently stands at 88.51, making it one of the most tracked metrics in Sai Life Sciences Ltd Ratios.

Historically, the Sai Life Sciences Ltd P/E ratio has shown strong fluctuations:

• 2024: 88.51
• 2023: 0
• 2022: 0
• 2021: 0

The rising Sai Life Sciences Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Sai Life Sciences Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.46.

Historical P/B trend:

• 2024: 7.46
• 2023: 0
• 2022: 0
• 2021: 0

Sai Life Sciences Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Sai Life Sciences Ltd P/S ratio currently stands at 8.88, an important part of Sai Life Sciences Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 8.88
• 2023: 0
• 2022: 0
• 2021: 0

The rising Sai Life Sciences Ltd P/S ratio indicates improved revenue valuation by investors.

Sai Life Sciences Ltd Price to Cash Flow Ratio (P/CF)

The Sai Life Sciences Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 54.28.

Historical Sai Life Sciences Ltd Price to Cash Flow Ratio:

• 2024: 54.28
• 2023: 0
• 2022: 0
• 2021: 0

The rising Sai Life Sciences Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Sai Life Sciences Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Sai Life Sciences Ltd EV currently stands at ₹149.06B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 149.06B
• 2023: 0
• 2022: 0
• 2021: 0

Sai Life Sciences Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Sai Life Sciences Ltd EV/EBITDA ratio is currently 36.02, a key metric in Sai Life Sciences Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 36.02
• 2023: 0
• 2022: 0
• 2021: 0

Higher Sai Life Sciences Ltd EV/EBITDA suggests premium valuation.

Sai Life Sciences Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Sai Life Sciences Ltd D/E ratio is currently 0.17, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.17
• 2023: 0.95
• 2022: 1.05
• 2021: 1.10

Sai Life Sciences Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Sai Life Sciences Ltd ROE currently stands at 10.96%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 10.96
• 2023: 8.89
• 2022: 1.13
• 2021: 0

Sai Life Sciences Ltd maintains stable profitability levels.

Sai Life Sciences Ltd Ratios Analysis Summary

The Sai Life Sciences Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Sai Life Sciences Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Sai Life Sciences Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.